In this regard, our group has demonstrated that tumor necrosis factor ɑ (TNFɑ) induces MUC4 expression in HER2+ breast cancer and converts trastuzumab-sensitive cell lines and tumors into resistant ones in vitro and in vivo [39,40]. Here, ERBB2 is linked to breast carcinoma.